Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer 5U01CA152662-13 Guillermo Marquez, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules 5R01CA252964-05 Claire Zhu, Ph.D.
Groninger, J. Hunter

Medstar Health Research Institute
United States

Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H.
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 3UG1CA189957-11S1 Vanessa A. White, M.P.H.
Grossman, Douglas

University Of Utah
United States

Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma 1R21CA289101-01A1 Nick Hodges, Ph.D.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 5R01CA270248-02
Hall, Daniel Lee

Massachusetts General Hospital
United States

Innovating CBT-I for Cancer Survivors: An Optimization Trial 5R21CA279248-02
Halmos, Balazs

Montefiore Medical Center (Bronx, Ny)
United States

Montefiore Academic Communicty NCORP Program 3UG1CA189859-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hanash, Samir M

University Of Tx Md Anderson Can Ctr
United States

Clinical Validation Center for Lung Cancer Early Detection 5U01CA271888-03 Guillermo Marquez, Ph.D.
Hanks, Brent Allen

Univ Of North Carolina Chapel Hill
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 7R01CA251136-05 Marjorie Perloff, M.D.